{"title":"诱变，“本质上的生物过程”和专利例外","authors":"Muriel Lightbourne","doi":"10.4337/QMJIP.2021.02.05","DOIUrl":null,"url":null,"abstract":"Recent developments in the field of European law, in relation to subject-matter consisting of living material, raise a string of basic issues as to the legal qualification of certain techniques used in agriculture and medicine, such as CRISPR-Cas9, and regarding their appraisal under European patent law. The present article reviews a series of decisions, including the decision of the Court of Justice of the European Union in case C-528/16, the decision issued on 7 February 2020 by the French Council of State and the Opinion of the European Patent Office Enlarged Board of Appeal of 14 May 2020 on Referral G 3/19.","PeriodicalId":42155,"journal":{"name":"Queen Mary Journal of Intellectual Property","volume":"11 1","pages":"219-242"},"PeriodicalIF":0.4000,"publicationDate":"2021-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Mutagenesis, ‘essentially biological processes’ and patent exceptions\",\"authors\":\"Muriel Lightbourne\",\"doi\":\"10.4337/QMJIP.2021.02.05\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Recent developments in the field of European law, in relation to subject-matter consisting of living material, raise a string of basic issues as to the legal qualification of certain techniques used in agriculture and medicine, such as CRISPR-Cas9, and regarding their appraisal under European patent law. The present article reviews a series of decisions, including the decision of the Court of Justice of the European Union in case C-528/16, the decision issued on 7 February 2020 by the French Council of State and the Opinion of the European Patent Office Enlarged Board of Appeal of 14 May 2020 on Referral G 3/19.\",\"PeriodicalId\":42155,\"journal\":{\"name\":\"Queen Mary Journal of Intellectual Property\",\"volume\":\"11 1\",\"pages\":\"219-242\"},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2021-05-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Queen Mary Journal of Intellectual Property\",\"FirstCategoryId\":\"90\",\"ListUrlMain\":\"https://doi.org/10.4337/QMJIP.2021.02.05\",\"RegionNum\":4,\"RegionCategory\":\"社会学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"LAW\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Queen Mary Journal of Intellectual Property","FirstCategoryId":"90","ListUrlMain":"https://doi.org/10.4337/QMJIP.2021.02.05","RegionNum":4,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"LAW","Score":null,"Total":0}
Mutagenesis, ‘essentially biological processes’ and patent exceptions
Recent developments in the field of European law, in relation to subject-matter consisting of living material, raise a string of basic issues as to the legal qualification of certain techniques used in agriculture and medicine, such as CRISPR-Cas9, and regarding their appraisal under European patent law. The present article reviews a series of decisions, including the decision of the Court of Justice of the European Union in case C-528/16, the decision issued on 7 February 2020 by the French Council of State and the Opinion of the European Patent Office Enlarged Board of Appeal of 14 May 2020 on Referral G 3/19.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
